Menu
Research Library
A curated library of peer-reviewed peptide studies and women's health publications — gathered in one place for easy reference.
For educational use only. All articles and studies linked here are provided for educational reference only. 1 amino does not own, endorse, or verify the data in these publications. External links lead to third-party sources we do not control. Nothing here is medical advice; products are for in-vitro research use only.
Women face substantially higher osteoporosis risk, especially after menopause. An overview of bone density, risk factors, and prevention from the NIH.
The copper tripeptide GHK-Cu has been studied for roles in wound healing, collagen synthesis, and skin remodeling. Explore the indexed studies on its regenerative signaling.
Polycystic ovary syndrome affects up to 1 in 10 women of reproductive age and is closely linked to insulin resistance. A plain-language reference on diagnosis and management.
A body of preclinical research has examined the pentadecapeptide BPC-157 for effects on tendon, ligament, muscle, and gut-tissue healing in animal models. Browse the indexed literature on PubMed.
An overview of menopause symptoms, timing, and the current evidence around hormone-therapy options, from the U.S. Office on Women’s Health.
In the SURMOUNT-1 trial, the dual GIP/GLP-1 receptor agonist tirzepatide led to dose-dependent weight reductions of up to 20.9% over 72 weeks — among the largest reported for a pharmacologic agent.
The STEP 1 randomized controlled trial found that once-weekly semaglutide 2.4 mg produced a mean 14.9% reduction in body weight over 68 weeks versus placebo, alongside improvements in cardiometabolic risk factors.